GlobeNewswire

Elite HTS Launches New Website & New Industry Standard

Share

VANCOUVER, British Columbia, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Today, Elite Home Theater Seating (Elite HTS) has yet again set the standard for custom home theater furniture with the launch of their new website EliteHTS.com and the announcement of their new Diamond Elite Certification for home theater furniture design. The brand, popular with the Hollywood elite and cinephiles worldwide, spent more than a year designing their new user experience and adding functionality to their popular custom chair builder.

“The new Elite HTS experience is one that we believe is a major step forward for home theater and cinema fans,” says Bobby Bala, CEO and founder of Elite. “We have taken great care to build a site that our industry partners can use on a daily basis to help their own businesses grow, as well as offering consumers a higher level of value than ever before.”

“But it goes beyond just how the site works,” adds Bala. “With the launch of our new site, we’re also excited to announce a new industry certification for home theater furniture design – the Diamond Elite Standard.”

The Diamond Elite Standard ensures that Elite’s discerning customers can be confident in the design and workmanship that goes into every custom home theater chair order. The standard defines ten key design and construction specifications that every chair must meet in order to be certified and receive the Diamond Elite seal. They include:

  1. Hand-crafted design – Every custom chair is made by hand and to bespoke customer specifications.
  2. All-wood construction – All wooden components must be made of solid wood without ‘thin’ composite materials.
  3. Single-piece base construction – Chair bases are made of a single piece of hollowed out wood to ensure stability and longevity.
  4. Fitted joinery – Fitted joints, glue and wood screws are used to provide superior chair strength over nails or staples.
  5. Reinforced arms – Improved reinforcements in each chair arm to eliminate typical squeaks and wobble.
  6. Material durability – All seating materials must meet or exceed international durability testing.
  7. German-designed mechanisms & motors – Reclining mechanisms and motors must meet or exceed strict German machinery designs and standards.
  8. Maximum 4″ recline clearance – Chairs must not exceed 4″ distance in headrest positioning when reclining.
  9. Chiropractor-approved – To eliminate muscle strain, all designs must be ergonomically approved.
  10. Superior warranty program – A full 10-year machinery warranty and 5-year foam and upholstery warranty.

“As one of the world’s premier luxury cinema chair manufacturers, this new standard offers consumers and designers alike a new benchmark for what quality and luxury truly mean,” notes Bala. “We also encourage theater seating companies worldwide to adopt the Diamond Elite Certification for their own product development.”

Industry partners and consumer clients are encouraged to visit EliteHTS.com to experience for themselves what luxury home theater seating is all about.

About Elite HTS
Elite HTS was founded with the mandate to bring a higher level of luxury and quality to the home theater seating market. Today, Elite HTS’ chairs have been featured in some of the finest high-end VIP and personal home cinemas in the world including the Venetian Hotel in Macau, Harrods in London, and the Technicolor Film Services screening rooms in Burbank, California. Elite HTS’ philosophy is centered on the 4Cs: Comfort, Craftsmanship, Customization, and Customer Service. To learn more about Elite’s Diamond-Certification as well as their customization options, visit www.EliteHTS.com.

Media Inquiries:
Cynthia Nerland
Director of Sales
Tel: (604) 575-8310
Email: cynthia@elitehts.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7c59f9e3-8591-41bc-92eb-00717dd747bc

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Norsk Hydro: PÅMINNELSE: Invitasjon - Presentasjon av Hydros resultat for andre kvartal 201919.7.2019 14:43:00 CESTPressemelding

Hydros resultat for andre kvartal 2019 blir offentliggjort tirsdag 23. juli 2019 kl. 07.00. Kvartalsrapporten og presentasjonsmaterialet blir samtidig gjort tilgjengelig på www.hydro.com. Presentasjon i Oslo Det blir holdt en kombinert analytikerpresentasjon og pressekonferanse ved Hydros hovedkontor i Drammensveien 260, Oslo, samme dag, kl. 08.30. Resultatet blir presentert av konsernsjef Hilde Merete Aasheim og konserndirektør for Økonomi og finans Eivind Kallevik. Hele presentasjonen kan sees direkte på web-TV. For påmelding, vennligst send mail til ir@hydro.com. I tillegg til web-TV, hvor det vil være mulig å stille spørsmål skriftlig, vil det også være mulig å ringe inn (ikke mulig å stille spørsmål over telefon). Du melder deg på denne telefonkonferansen ved å ringe: Norge +47 2100 2610 UK +44 (0)330 336 9125 USA +1 929-477-0324 Sverige +46 (0)8 5033 6574 Brasil +55 11 3181 5427 Tyskland +49 (0)89 20303 5709 Kode: 3104804 Q&A / Telefonkonferanse Det blir holdt en telefonkonferans

Norsk Hydro: REMINDER: Invitation - Hydro’s second quarter results 201919.7.2019 14:43:00 CESTPress release

Hydro's second quarter results 2019 will be released at 07:00 CEST (01:00 AM EDT, 06:00 UK time), on Tuesday July 23, 2019. The quarterly report and presentation slides will be available on www.hydro.com at the same time. Presentation in Oslo Hydro will host a combined analyst and press conference, in English, at its corporate headquarters at Drammensveien 260, Oslo, at 08:30 CEST the same day. The presentation will be held by President and CEO Hilde Merete Aasheim and CFO Eivind Kallevik and can also be seen on web TV. To attend the presentation in Oslo, please register by sending a mail to ir@hydro.com. In addition to the webcast, where it will be possible to ask questions in writing, it will also be possible to dial in (not possible to ask questions over the phone). Dial-in numbers for this conference call are: Norway +47 2100 2610 UK +44 (0)330 336 9125 USA +1 929-477-0324 Sweden +46 (0)8 5033 6574 Brazil +55 11 3181 5427 Germany +49 (0)89 20303 5709 Confirmation Code: 3104804 Q&A

Sunstone Life Science Ventures invests in Karolinska Development's portfolio company Forendo Pharma19.7.2019 14:00:00 CESTPressemelding

STOCKHOLM – July 19, 2019. Karolinska Development's portfolio company Forendo Pharma announces today that Sunstone Life Science Ventures joins the existing international investor syndicate and has made a EUR 5 million investment in Forendo Pharma. Claus Andersson, General Partner from Sunstone, joins Forendo Pharma’s Board of Directors. With the investment, Sunstone joins the existing international investor syndicate comprising Novo Seeds, Karolinska Development, Innovestor, Novartis Venture Fund, M Ventures and Vesalius Biocapital Partners. The new financing will enable Forendo Pharma to progress its lead endometriosis program, FOR-6219, an HSD17B1 enzyme inhibitor, into the next phase of clinical studies after the successful completion of its Phase 1a study earlier this year. Endometriosis is a chronic condition that affects many women of reproductive age and causes repeated pain symptoms, infertility and impaired quality of life. Currently available treatments for endometriosis have

Sunstone Life Science Ventures invests in Karolinska Development's portfolio company Forendo Pharma19.7.2019 14:00:00 CESTPress release

STOCKHOLM – July 19, 2019. Karolinska Development's portfolio company Forendo Pharma announces today that Sunstone Life Science Ventures joins the existing international investor syndicate and has made a EUR 5 million investment in Forendo Pharma. Claus Andersson, General Partner from Sunstone, joins Forendo Pharma’s Board of Directors. With the investment, Sunstone joins the existing international investor syndicate comprising Novo Seeds, Karolinska Development, Innovestor, Novartis Venture Fund, M Ventures and Vesalius Biocapital Partners. The new financing will enable Forendo Pharma to progress its lead endometriosis program, FOR-6219, an HSD17B1 enzyme inhibitor, into the next phase of clinical studies after the successful completion of its Phase 1a study earlier this year. Endometriosis is a chronic condition that affects many women of reproductive age and causes repeated pain symptoms, infertility and impaired quality of life. Currently available treatments for endometriosis have

RAPALA VMC CORPORATION’S HALF YEAR REPORT H1/2019: SALES AND PROFITABILITY DECREASED FROM LAST YEAR – FULL YEAR GUIDANCE UNCHANGED19.7.2019 12:00:00 CESTPress release

Rapala VMC Corporation Half year financial report July 19, 2019 at 1:00 p.m. RAPALA VMC CORPORATION’S HALF YEAR REPORT H1/2019: SALES AND PROFITABILITY DECREASED FROM LAST YEAR – FULL YEAR GUIDANCE UNCHANGED January-June (H1) in brief: Net sales were 141.2 MEUR, down 1% from previous year (142.5). With comparable exchange rates sales were 2% lower than last year. Operating profit was 11.4 MEUR (15.3), down 25%.1) Comparable operating profit* was 12.0 MEUR (15.2), down 21%. 1) Cash flow from operations was 11.5 MEUR (5.9). 2) Earnings per share was 0.17 EUR (0.23), down 26%. Full year guidance unchanged: Full year net sales with comparable FX rates expected to be around last year’s level and comparable operating profit* to increase from last year. Strong second half of the year expected: record strong order book in North America, improvements in Indonesian lure factory combined with rigorous management of fixed costs. Uncertainties and risks relate to US-China trade relations, global ec